Cancer incidence and mortality in China, Chin J Cancer Res, vol.30, pp.1-12, 2014. ,
CA, Cancer statistics, vol.68, pp.7-30, 2018. ,
Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells, Free Radic Biol Med, vol.89, pp.263-73, 2015. ,
Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade, Cell, vol.167, pp.1540-54, 2016. ,
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2, Mol Ther: J Am Soc Gene Ther, vol.18, pp.843-51, 2010. ,
, Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated
Cancer treatment and survivorship statistics, Cancer J Clin, vol.66, pp.271-89, 2016. ,
Pharmacologic resistance in colorectal cancer: a review, Therapeutic Adv Med Oncol, vol.8, pp.57-84, 2016. ,
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, Lancet, vol.355, pp.1041-1048, 2000. ,
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group, New Engl J Med, vol.343, pp.905-919, 2000. ,
Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-74, 2011. ,
Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, vol.324, pp.1029-1062, 2009. ,
Glucose transporters in cancer metabolism, Curr Opin Oncol, vol.24, pp.650-654, 2012. ,
Glucose metabolism and cancer, Curr Opin Cell Biol, vol.18, pp.598-608, 2006. ,
Why cancer & metabolism? Why now?, Cancer Metab, vol.1, p.1, 2013. ,
Targeting cellular metabolism to improve cancer therapeutics, Cell Death Dis, vol.4, p.532, 2013. ,
Regulation of cancer cell metabolism, Nat Rev Cancer, vol.11, pp.85-95, 2011. ,
Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia, Cancer Res, vol.65, pp.613-634, 2005. ,
MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer, Hepatology, vol.62, pp.1132-1176, 2015. ,
MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells, Gastroenterology, vol.149, pp.1587-98, 2015. ,
MicroRNA-129-5p regulates glycolysis and cell proliferation by targeting the glucose transporter SLC2A3 in gastric cancer cells, Front Pharmacol, vol.9, p.502, 2018. ,
MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, vol.116, pp.281-97, 2004. ,
MicroRNAs in Cancer, Annu Rev Med, vol.60, pp.167-79, 2009. ,
microRNAs: tiny RNA molecules, huge driving forces to move the cell, Protein Cell, vol.1, pp.916-942, 2010. ,
MicroRNAs are important regulators of drug resistance in colorectal cancer, Biol Chem, vol.398, pp.929-967, 2017. ,
Efficacy of dichloroacetate as a lactate-lowering drug, J Clin Pharmacol, vol.43, pp.683-91, 2003. ,
Dichloroacetate and cancer: new home for an orphan drug?, Biochim Biophys Acta, vol.1846, pp.617-646, 2014. ,
Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex, Biochemical J, vol.329, pp.191-197, 1998. ,
A mitochondria-K + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth, Cancer cell, vol.11, pp.37-51, 2007. ,
Metabolic modulation of glioblastoma with dichloroacetate, Sci Transl Med, vol.2, pp.31-35, 2010. ,
A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors, Invest New Drugs, vol.33, pp.603-613, 2015. ,
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?, Int J Cancer, vol.128, pp.1001-1009, 2011. ,
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer, Br J Cancer, vol.99, pp.989-94, 2008. ,
Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells, Br J Cancer, vol.102, pp.1746-52, 2010. ,
Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia, Cancer Lett, vol.297, pp.75-83, 2010. ,
MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer, Theranostics, vol.5, pp.1122-1165, 2015. ,
18beta-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling, Oncotarget, vol.7, pp.71960-73, 2016. ,
Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway, Br J Pharm, vol.174, pp.553-68, 2017. ,
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol, Structure, vol.15, pp.992-1004, 2007. ,
Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells, FEBS J, vol.272, pp.3004-3018, 2005. ,
Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype, Br J Pharm, vol.171, pp.3255-67, 2014. ,
The pharmacology of dichloroacetate, Metab: Clin Exp, vol.38, pp.1124-1168, 1989. ,
Age-dependent kinetics and metabolism of dichloroacetate: possible relevance to toxicity, J Pharmacol Exp Therap, vol.324, pp.1163-71, 2008. ,
Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect, Cancer Res, vol.73, pp.7277-89, 2013. ,
Inactivation of the HIF-1alpha/ PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants, Cancer Res, vol.72, pp.5035-5082, 2012. ,
Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism, Exp Cell Res, vol.321, pp.219-249, 2014. ,
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma, Br J Cancer, vol.108, pp.72-81, 2013. ,
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer, Cancer Lett, vol.371, pp.20-29, 2016. ,
Autophagy and tumor metabolism, Cell Metab, vol.25, pp.1037-1080, 2017. ,
Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer. Oncogene, vol.32, pp.1638-50, 2013. ,
Diversity of the pyruvate dehydrogenase kinase gene family in humans, J Biol Chem, vol.270, pp.28989-94, 1995. ,
Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs, Am J Physiol Endocrinol Metab, vol.284, pp.855-62, 2003. ,
The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis, Oncogene, vol.36, pp.989-98, 2017. ,
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells, Cell Death Differ, vol.25, pp.1224-1262, 2018. ,
The genetics of the p53 pathway, apoptosis and cancer therapy, Nat Rev Drug Discov, vol.7, pp.979-87, 2008. ,
The p53 tumor suppressor in the control of metabolism and ferroptosis, Front Endocrinol, vol.9, p.124, 2018. ,
p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2, Cancer Res, vol.72, pp.560-567, 2012. ,
TP53 mutation in colorectal cancer, Hum Mutat, vol.21, pp.271-277, 2003. ,
Cancer's molecular sweet tooth and the Warburg effect, Cancer Res, vol.66, pp.8927-8957, 2006. ,
ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1, PLoS Pathog, vol.14, p.1007394, 2018. ,
Targeting SLC25A10 alleviates improved antioxidant capacity and associated radioresistance of cancer cells induced by chronic-cycling hypoxia, Cancer Lett, vol.439, pp.24-38, 2018. ,